Status of Iran’s Nuclear Program, and More from CRS
New and newly updated reports from the Congressional Research Service which have not been made publicly available include the following.
Iran’s Nuclear Program: Status, updated September 26, 2012
Israel: Possible Military Strike Against Iran’s Nuclear Facilities, updated September 28, 2012
Senkaku (Diaoyu/Diaoyutai) Islands Dispute: U.S. Treaty Obligations, September 25, 2012
Armenia, Azerbaijan, and Georgia: Political Developments and Implications for U.S. Interests, updated September 27, 2012
Military Medical Care: Questions and Answers, updated September 27, 2012
The Family and Medical Leave Act (FMLA): An Overview, September 28, 2012
Fannie Mae’s and Freddie Mac’s Financial Status: Frequently Asked Questions, September 27, 2012
Surface Transportation Funding and Programs Under MAP-21: Moving Ahead for Progress in the 21st Century Act (P.L. 112-141), September 27, 2012
The Exon-Florio National Security Test for Foreign Investment, updated October 1, 2012
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.
As the efficacy of environmental laws has waned, so has their durability. What was once a broadly shared goal – protecting Americans from environmental harm – is now a political football, with rules that whipsaw back and forth depending on who’s in charge.
It takes the average person over 9 hours and costs $160 to file taxes each year. IRS Direct File meant it didn’t have to.
It’s paramount to balance both innovation capabilities and risk as we work towards ensuring that the U.S. bioeconomy is a priority area for both the Nation and for National Security.